Moderna ties up with Immatics to boost cancer vaccine development

The companies would use Immatics’ drug discovery platform to develop mRNA-based cancer vaccines. Read more at straitstimes.com.

CAMBRIDGE, Massachusetts – Moderna said on Monday it has struck a deal with German drug developer Immatics for developing cancer vaccines and therapies, and would pay US$120 million in cash and additional milestone payments.

Moderna said the companies would use Immatics’ drug discovery platform to develop mRNA-based cancer vaccines, and also study its own cancer vaccine for use in combination with Immatics’ cancer therapy IMA203. The deal is the latest in Moderna’s push to expand beyond Covid-19 as demand for the shots falls dramatically, and develop a vaccine for cancer, a dream that scientists have chased for decades with little success.

Moderna is already developing a cancer vaccine with Merck, which was shown to cut the risk of recurrence or death by 44 per cent in patients with deadly skin cancer melanoma, in a mid-stage trial.Under the terms of collaboration, Moderna will lead the development and commercialisation of the cancer vaccines resulting from the collaboration, while Immatics will be responsible for pre-clinical and potential early-stage studies.

Immatics will also receive research funding and is eligible for development, regulatory, and commercial milestone payments that could exceed US$1.7 billion, Moderna said. REUTERS

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

straits_times /  🏆 5. in SG

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

In Pictures: Aftermath of Morocco earthquakeRead more at straitstimes.com.
Read more »

NTU professor first Singapore winner of Apec science prize from 16 nomineesNTU professor first Singaporean winner of globally recognised APEC science prize Read more at straitstimes.com.
Read more »

In Pictures: The RSAF55 Open HouseRead more at straitstimes.com.
Read more »

NTU professor first Singapore winner of Apec science prizeNTU professor first Singaporean winner of globally recognised APEC science prize Read more at straitstimes.com.
Read more »